BusinessInnovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live WebinarBy Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessNew “Test and Treatment” Allergy Program Enables All Physicians To Provide Convenient And Effective Allergy CareBy Nasdaq OMXDec 19, 2017, 1:17 PM UTC
BusinessClinical Data for eFFECTOR Therapeutics’ Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated Safety ProfileBy Nasdaq OMXDec 11, 2017, 3:00 PM UTC
BusinessJounce Therapeutics to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare ConferenceBy Nasdaq OMXDec 7, 2017, 1:01 PM UTC
BusinesseFFECTOR Therapeutics Presents Preclinical Data for eFT508 that Demonstrates Beneficial Immunological EffectsBy Nasdaq OMXNov 10, 2017, 3:00 PM UTC
BusinessVBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017By Nasdaq OMXNov 10, 2017, 1:00 PM UTC
BusinessOmniSeq Receives CAP Accreditation and Publishes Analytical Validation PaperBy Nasdaq OMXNov 9, 2017, 1:02 PM UTC
